Guardant Health

NCT03615443

Noninvasive vs. Invasive Lung Evaluation

NCT03746262

Changes in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung Cancer

NCT03248089

Spanish Lung Liquid vs. Invasive Biopsy Program (SLLIP)

NCT03791034

Cell Free DNA for the Diagnosis and Treatment in Early NSCLC

NCT03774758

Biomarkers for Risk Stratification in Lung Cancer

NCT03477474

Registry of Guardant360® Use and Outcomes In People With Advanced Cancer

NCT03625557

Guardant360® Test-Related Clinical Outcomes in Patients Who Share Medical Records

NCT04087473

Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC

NCT04136002

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

NCT04436393

Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer

NCT04497285

Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer

NCT05641870

Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC

NCT05021146

Essential Oil for Chronic Low Back Pain

NCT05059444

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05117840

Screening for High Frequency Malignant Disease

NCT05716477

Blood Test (Guardant Shield™) for Screening of Colorectal Cancer in Underserved Patients

NCT05703243

"Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting (DINOSAur II)"

NCT05885009

Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)

NCT05935384

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

NCT06444542

Understanding Patient Preference on Colorectal Cancer Screening Options-PSU

NCT06910618

A Multicenter Prospective Observational Study on Vertebral Fracture Risk Stratification in Patients With Vertebral Metastases

NCT06880055

Shield Post-Approval Study Protocol